Yahoo Web Search

Search results

    • Amgen Investors Await Weight-Loss Drug Data

      US News & World Report· 5 days ago

      Amgen has said it expects to have first-in-human results from a small, early-stage trial of experimental oral compound AMG786 before the end of June. "We are still collecting ...